Polaris Venture Management Co V’s Genocea Biosciences, Inc. GNCA Stock Holding History

Polaris Venture Management Co V’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$379K	Hold	197,345	–	–	2.69%	5
2021 Q2	$462K	Hold	197,345	–	–	0.74%	6
2021 Q1	$535K	Hold	197,345	–	–	0.69%	7
2020 Q4	$478K	Hold	197,345	–	–	0.62%	6
2020 Q3	$452K	Sell	197,345 -48,733	-20%	-$128K	0.75%	6
2020 Q2	$566K	Hold	246,078	–	–	0.44%	9
2020 Q1	$423K	Hold	246,078	–	–	0.38%	7
2019 Q4	$509K	Hold	246,078	–	–	0.37%	9
2019 Q3	$714K	Hold	246,078	–	–	0.41%	8
2019 Q2	$965K	Buy	246,078 +2	+0%	+$10	0.76%	9
2019 Q1	$1.16M	Hold	246,076	–	–	0.98%	9
2018 Q4	$565K	Hold	246,076	–	–	0.6%	11
2018 Q3	$1.53M	Hold	246,076	–	–	0.77%	9
2018 Q2	$1.69M	Hold	246,076	–	–	0.92%	9
2018 Q1	$2.07M	Hold	246,076	–	–	1.18%	9
2017 Q4	$2.28M	Hold	246,076	–	–	2.01%	9
2017 Q3	$2.87M	Hold	246,076	–	–	2.47%	8
2017 Q2	$10.3M	Hold	246,076	–	–	10.63%	3
2017 Q1	$12M	Hold	246,076	–	–	12.83%	3
2016 Q4	$8.11M	Hold	246,076	–	–	9.63%	4
2016 Q3	$10.1M	Hold	246,076	–	–	10.64%	4
2016 Q2	$8.07M	Hold	246,076	–	–	8.66%	4
2016 Q1	$15.2M	Hold	246,076	–	–	14.56%	3
2015 Q4	$10.4M	Hold	246,076	–	–	8.15%	6
2015 Q3	$13.5M	Hold	246,076	–	–	9.19%	6
2015 Q2	$27M	Sell	246,076 -10,828	-4%	-$1.01M	12.05%	4
2015 Q1	$24.4M	Hold	256,904	–	–	10.89%	5
2014 Q4	$14.4M	Hold	256,904	–	–	11.38%	4
2014 Q3	$18.6M	Sell	256,904 -9,181	-3%	-$1.01M	14.35%	3
2014 Q2	$39.9M	Hold	266,085	–	–	32.52%	1
2014 Q1	$38.7M	Buy	+266,085	New	+$32.6M	32.16%	1

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Polaris Venture Management Co V's GNCA Position: Q3 2021 in Review

Polaris Venture Management Co V held its Genocea Biosciences, Inc. (GNCA) position steady in Q3 2021 at 197,345 shares worth $379K. The position accounts for 2.69% of the portfolio, ranked #5.

Polaris Venture Management Co V first reported a position in GNCA in Q1 2014 and has held it in 31 quarters since. The position peaked at $39.9M in Q2 2014. 40 funds tracked by Wall St. Rank hold GNCA as of Q3 2021.

Polaris Venture Management Co V held 197,345 shares of Genocea Biosciences, Inc. worth $379K as of Q3 2021.
Polaris Venture Management Co V left its Genocea Biosciences, Inc. share count unchanged in Q3 2021.
Genocea Biosciences, Inc. made up 2.69% of Polaris Venture Management Co V's portfolio in Q3 2021, its #5 holding.
Polaris Venture Management Co V first reported a position in Genocea Biosciences, Inc. in Q1 2014 and has held it in 31 quarters since.
Polaris Venture Management Co V's Genocea Biosciences, Inc. position peaked at $39.9M in Q2 2014.
40 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2021.

Based on Polaris Venture Management Co V's 13F filing for Q3 2021, filed 12 Nov 2021.